612 / 1835
Conclusions
•
Targeted therapies may potentially change the
landscape of therapy for DLBCL..not yet
•
Much still needs to be proved and phase III
studies (no matter how difficult) are
needed..and how to sequence
•
We need to continue to better understand and
exploit the biology.